A share price of MBX Biosciences Inc [MBX] is currently trading at $13.95, up 3.18%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MBX shares have lost -12.04% over the last week, with a monthly amount glided 43.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MBX Biosciences Inc [NASDAQ: MBX] stock has seen the most recent analyst activity on October 15, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $50. On August 05, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $38 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $38 on July 16, 2025. Citizens JMP initiated its recommendation with a Mkt Outperform and recommended $38 as its price target on April 10, 2025. Stifel started tracking with a Buy rating for this stock on October 08, 2024, and assigned it a price target of $40. In a note dated October 08, 2024, JP Morgan initiated an Overweight rating and provided a target price of $30 on this stock.
MBX Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.81 and $27.50. Currently, Wall Street analysts expect the stock to reach $38 within the next 12 months. MBX Biosciences Inc [NASDAQ: MBX] shares were valued at $13.95 at the most recent close of the market. An investor can expect a potential return of 172.4% based on the average MBX price forecast.
Analyzing the MBX fundamentals
Gross Profit Margin for this corporation currently stands at -0.75% with Operating Profit Margin at -389.89%, Pretax Profit Margin comes in at -346.93%, and Net Profit Margin reading is -346.93%. To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.31 and Total Capital is -0.39. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for MBX Biosciences Inc [NASDAQ:MBX] is 19.50. As well, the Quick Ratio is 19.50, while the Cash Ratio is 3.38.
Transactions by insiders
Recent insider trading involved Heron Patrick J, Director, that happened on Sep 26 ’25 when 0.67 million shares were purchased. Director, Pescovitz Ora H. completed a deal on Apr 08 ’25 to buy 7693.0 shares. Meanwhile, Director GORDON CARL L bought 0.14 million shares on Feb 18 ’25.
